INC Research Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.54
- Today's High:
- $1.67
- Open Price:
- $1.67
- 52W Low:
- $1.39
- 52W High:
- $5.56
- Prev. Close:
- $1.7
- Volume:
- 61626
Company Statistics
- Market Cap.:
- $71.09 million
- Book Value:
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $102.56 million
- Profit Margin:
- 7.77%
- Return on Assets TTM:
- 2.07%
- Return on Equity TTM:
- 5.79%
Company Profile
INC Research Holdings Inc had its IPO on 2014-11-07 under the ticker symbol INCR.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. INC Research Holdings Inc has a staff strength of 370 employees.
Stock update
Shares of INC Research Holdings Inc opened at $1.67 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.54 - $1.67, and closed at $1.54.
This is a -9.41% slip from the previous day's closing price.
A total volume of 61,626 shares were traded at the close of the day’s session.
In the last one week, shares of INC Research Holdings Inc have slipped by -1.28%.
INC Research Holdings Inc's Key Ratios
INC Research Holdings Inc has a market cap of $71.09 million, indicating a price to book ratio of 1.3914 and a price to sales ratio of 1.656.
In the last 12-months INC Research Holdings Inc’s revenue was $0 with a gross profit of $102.56 million and an EBITDA of $0. The EBITDA ratio measures INC Research Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, INC Research Holdings Inc’s operating margin was 0% while its return on assets stood at 2.07% with a return of equity of 5.79%.
In Q2, INC Research Holdings Inc’s quarterly earnings growth was a negative -98.6% while revenue growth was a positive 21.7%.
INC Research Holdings Inc’s PE and PEG Ratio
- Forward PE
- 6.9396
- Trailing PE
- 10.4
- PEG
Its diluted EPS in the last 12-months stands at $0.15 per share while it has a forward price to earnings multiple of 6.9396 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into INC Research Holdings Inc’s profitability.
INC Research Holdings Inc stock is trading at a EV to sales ratio of 0.5515 and a EV to EBITDA ratio of 2.5562. Its price to sales ratio in the trailing 12-months stood at 1.656.
INC Research Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $841.85 million
- Total Liabilities
- $207.75 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $3806
- Dividend Payout Ratio
- 0%
INC Research Holdings Inc ended 2024 with $841.85 million in total assets and $0 in total liabilities. Its intangible assets were valued at $841.85 million while shareholder equity stood at $508.76 million.
INC Research Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $207.75 million in other current liabilities, 634383000.00 in common stock, $-136552000.00 in retained earnings and $284.18 million in goodwill. Its cash balance stood at $102.65 million and cash and short-term investments were $102.85 million. The company’s total short-term debt was $57,478,000 while long-term debt stood at $84.07 million.
INC Research Holdings Inc’s total current assets stands at $394.50 million while long-term investments were $42.57 million and short-term investments were $192000.00. Its net receivables were $134.37 million compared to accounts payable of $104.61 million and inventory worth $143.50 million.
In 2024, INC Research Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $3806.
Comparatively, INC Research Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.54
- 52-Week High
- $5.56
- 52-Week Low
- $1.39
- Analyst Target Price
- $25.7
INC Research Holdings Inc stock is currently trading at $1.54 per share. It touched a 52-week high of $5.56 and a 52-week low of $5.56. Analysts tracking the stock have a 12-month average target price of $25.7.
Its 50-day moving average was $1.59 and 200-day moving average was $2.57 The short ratio stood at 0.35 indicating a short percent outstanding of 0%.
Around 3579.6% of the company’s stock are held by insiders while 920.1% are held by institutions.
Frequently Asked Questions About INC Research Holdings Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.